This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ruiz, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruiz, N.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 2009, p. 3604-3605, Vol. 53, No. 8
0066-4804/09/$08.00+0     doi:10.1128/AAC.00578-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

LETTER TO THE EDITOR

Streptococcus pyogenes YtgP (Spy_0390) Complements Escherichia coli Strains Depleted of the Putative Peptidoglycan Flippase MurJ{triangledown}


arrow
LETTER
 
Most bacteria possess peptidoglycan (PG), an extracytoplasmic polymer that protects them from osmotic lysis and that serves as an anchor for cellular components, including virulence factors (10). PG biogenesis is the target of many antibiotics, but increasing resistance is rendering many such antibiotics ineffective (6). Recently, MurJ (formerly MviN) has been shown essential for PG biogenesis in Escherichia coli and has been proposed to function as the flippase that translocates the PG precursor lipid II across the cytoplasmic membrane (3, 7). Because of the clear potential of MurJ as a novel antibiotic target, we need to understand both how MurJ functions and how conserved MurJ is in bacteria.

A BLASTP 2.2.20+ search (1, 2) revealed that MurJ is highly conserved among gram-negative bacteria (Proteobacteria) but not among 21 genomes representative of the gram-positive Firmicutes (including Bacillus, Listeria, Staphylococcus, Enterococcus, and Streptococcus), since it found only one protein with an E value of <0.01, YtgP (locus tag BSU30050) of Bacillus subtilis subsp. strain 168. Failure to identify the putative PG flippase in key gram-positive pathogens begged the question of whether these organisms have an ortholog that does not share a high degree of sequence homology with E. coli MurJ or whether they flip lipid II through a different mechanism. The first possibility seemed more likely, since BLASTP revealed that Bacillus YtgP is highly conserved among Firmicutes.

To investigate whether YtgP is the E. coli MurJ ortholog, I tested whether YtgP complements MurJ-depleted E. coli cells. The algorithm ParAlign, which is more sensitive than BLASTP(8), showed that there are several YtgP paralogs in B. subtilis (EpsK, SpoVB, YfkQ, and YabM); therefore, I chose the YtgP from an organism encoding a single ortholog, namely, Spy_0390 (GenBank accession no. AAK33429.1) from Streptococcus pyogenes. First, the Spy_0390 gene from S. pyogenes M6 strain HSC5 was amplified using PCR primers Sp5ORF0390 (5'-GCCTCGACAGAAAAAAAACAACTGACACAAGAAGAATTG) and Sp3ORF0390 (5'-CCATGCCAGCCTAATTTCTGACGAAGGCGACT), and the blunt-ended product was introduced into StuI-digested pCA24N(-gfp) (4) to yield pSpyMurJ1, which produces Spy_0390 under the control of an isopropyl-β-D-thiogalactopyranoside (IPTG)-inducible promoter as a hybrid protein with an N-terminal MRGS-His6-TDPALRA peptide fused to its second amino acid and a C-terminal GLCGR peptide fused to its last amino acid. For controls, ASKA collection (4) plasmids pCA24N(-gfp) and its derivative carrying the E. coli murJ were used and renamed pCA24Not and pEcMurJ1, respectively. Chloramphenicol (20 µg/ml) was used for plasmid selection.

Vectors pCA24Not, pEcMurJ1, and pSpyMurJ1 were introduced into E. coli strain NR1152, which produces MurJ in the presence of arabinose but lyses when grown in the absence of arabinose because of the depletion of MurJ (7). To quantify complementation, efficiency of plating values of overnight cultures were determined by plating serial dilutions on Luria-Bertani (LB) medium alone and LB medium containing either arabinose or IPTG (Table 1). An efficiency of plating value of 1 was assigned to E. coli NR1152(pCA24Not) plated on LB containing arabinose. As expected, strain NR1152(pCA24Not) only grew with arabinose. E. coli NR1152(pEcMurJ1) grew with arabinose or IPTG; it also grew on LB owing to leaky expression of E. coli murJ from the plasmid (4). E. coli NR1152(pSpyMurJ1) grew well with arabinose and not without arabinose, but IPTG fully restored growth, albeit it yielded smaller colonies than NR1152(pEcMurJ1) did. The lower rate of growth of E. coli NR1152(pSpyMurJ1) compared to NR1152(pEcMurJ1) is likely caused by lower expression of the streptococcal protein owing to differences in codon usage between the two bacteria, since the streptococcal sequence includes several codons rarely used in E. coli. Moreover, passage of E. coli NR1152(pSpyMurJ1) through medium containing high levels of IPTG selected for mutations in the IPTG-inducible promoter region of pSpyMurJ1 that restored wild-type colony size. Restoration of wild-type growth was proven to be linked to these promoter mutations in the plasmid; thus, once appropriate levels of Spy_0390 gene expression are achieved, Spy_0390 protein complements fully.


View this table:
[in this window]
[in a new window]

 
TABLE 1. Efficiency of plating values of E. coli strain NR1152 carrying pCA24Not-derived plasmids on various media

These results indicate that Spy_0390 and E. coli MurJ are functional homologs, so they suggest that YtgP orthologs, which are widely spread among gram-positive bacteria, likely function as PG lipid II flippases. As expected from such function, YtgP is essential in S. pneumoniae and Staphylococcus aureus (9, 11). Notably, YtgP is not essential in B. subtilis probably because of redundancy among the aforementioned paralogs (5). The cross-phylum complementation reported here has two implications important for the development of MurJ inhibitors. First, because lipid II in E. coli differs from that of S. pyogenes (10), MurJ likely recognizes features in lipid II that are common in both phyla, namely, the undecaprenyl-pyrophosphoryl disaccharide. Second, it might be possible to find inhibitors of these putative lipid II flippases that will be broad-spectrum antibiotics.


arrow
ACKNOWLEDGMENTS
 
I thank Thomas J. Silhavy for his support and Mark J. Mandel for his helpful suggestions regarding the manuscript. I thank Michael Federle for kindly providing strain HSC5.

This work was supported by National Institute of General Medical Sciences grant GM34821.


arrow
FOOTNOTES
 
{triangledown} Published ahead of print on 15 June 2009. Back


arrow
REFERENCES
 
    1
  1. Altschul, S. F., T. L. Madden, A. A. Schaffer, J. Zhang, Z. Zhang, W. Miller, and D. J. Lipman. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389-3402.[Abstract/Free Full Text]
  2. 2
  3. Altschul, S. F., J. C. Wootton, E. M. Gertz, R. Agarwala, A. Morgulis, A. A. Schaffer, and Y. K. Yu. 2005. Protein database searches using compositionally adjusted substitution matrices. FEBS J. 272:5101-5109.[CrossRef][Medline]
  4. 3
  5. Inoue, A., Y. Murata, H. Takahashi, N. Tsuji, S. Fujisaki, and J. Kato. 2008. Involvement of an essential gene, mviN, in murein synthesis in Escherichia coli. J. Bacteriol. 190:7298-7301.[Abstract/Free Full Text]
  6. 4
  7. Kitagawa, M., T. Ara, M. Arifuzzaman, T. Ioka-Nakamichi, E. Inamoto, H. Toyonaga, and H. Mori. 2005. Complete set of ORF clones of Escherichia coli ASKA library (a complete set of E. coli K-12 ORF archive): unique resources for biological research. DNA Res. 12:291-299.[Abstract/Free Full Text]
  8. 5
  9. Kobayashi, K., S. D. Ehrlich, A. Albertini, G. Amati, K. K. Andersen, M. Arnaud, K. Asai, S. Ashikaga, S. Aymerich, P. Bessieres, F. Boland, S. C. Brignell, S. Bron, K. Bunai, J. Chapuis, L. C. Christiansen, A. Danchin, M. Debarbouille, E. Dervyn, E. Deuerling, K. Devine, S. K. Devine, O. Dreesen, J. Errington, S. Fillinger, S. J. Foster, Y. Fujita, A. Galizzi, R. Gardan, C. Eschevins, T. Fukushima, K. Haga, C. R. Harwood, M. Hecker, D. Hosoya, M. F. Hullo, H. Kakeshita, D. Karamata, Y. Kasahara, F. Kawamura, K. Koga, P. Koski, R. Kuwana, D. Imamura, M. Ishimaru, S. Ishikawa, I. Ishio, D. Le Coq, A. Masson, C. Mauel, R. Meima, R. P. Mellado, A. Moir, S. Moriya, E. Nagakawa, H. Nanamiya, S. Nakai, P. Nygaard, M. Ogura, T. Ohanan, M. O'Reilly, M. O'Rourke, Z. Pragai, H. M. Pooley, G. Rapoport, J. P. Rawlins, L. A. Rivas, C. Rivolta, A. Sadaie, Y. Sadaie, M. Sarvas, T. Sato, H. H. Saxild, E. Scanlan, W. Schumann, J. F. Seegers, J. Sekiguchi, A. Sekowska, S. J. Seror, M. Simon, P. Stragier, R. Studer, H. Takamatsu, T. Tanaka, M. Takeuchi, H. B. Thomaides, V. Vagner, J. M. van Dijl, K. Watabe, A. Wipat, H. Yamamoto, M. Yamamoto, Y. Yamamoto, K. Yamane, K. Yata, K. Yoshida, H. Yoshikawa, U. Zuber, and N. Ogasawara. 2003. Essential Bacillus subtilis genes. Proc. Natl. Acad. Sci. USA 100:4678-4683.[Abstract/Free Full Text]
  10. 6
  11. Mainardi, J. L., R. Villet, T. D. Bugg, C. Mayer, and M. Arthur. 2008. Evolution of peptidoglycan biosynthesis under the selective pressure of antibiotics in Gram-positive bacteria. FEMS Microbiol. Rev. 32:386-408.[CrossRef][Medline]
  12. 7
  13. Ruiz, N. 2008. Bioinformatics identification of MurJ (MviN) as the peptidoglycan lipid II flippase in Escherichia coli. Proc. Natl. Acad. Sci. USA 105:15553-15557.[Abstract/Free Full Text]
  14. 8
  15. Saebo, P. E., S. M. Andersen, J. Myrseth, J. K. Laerdahl, and T. Rognes. 2005. PARALIGN: rapid and sensitive sequence similarity searches powered by parallel computing technology. Nucleic Acids Res. 33:W535-W539.[Abstract/Free Full Text]
  16. 9
  17. Thanassi, J. A., S. L. Hartman-Neumann, T. J. Dougherty, B. A. Dougherty, and M. J. Pucci. 2002. Identification of 113 conserved essential genes using a high-throughput gene disruption system in Streptococcus pneumoniae. Nucleic Acids Res. 30:3152-3162.[Abstract/Free Full Text]
  18. 10
  19. Vollmer, W., D. Blanot, and M. A. de Pedro. 2008. Peptidoglycan structure and architecture. FEMS Microbiol. Rev. 32:149-167.[CrossRef][Medline]
  20. 11
  21. Zalacain, M., S. Biswas, K. A. Ingraham, J. Ambrad, A. Bryant, A. F. Chalker, S. Iordanescu, J. Fan, F. Fan, R. D. Lunsford, K. O'Dwyer, L. M. Palmer, C. So, D. Sylvester, C. Volker, P. Warren, D. McDevitt, J. R. Brown, D. J. Holmes, and M. K. Burnham. 2003. A global approach to identify novel broad-spectrum antibacterial targets among proteins of unknown function. J. Mol. Microbiol. Biotechnol. 6:109-126.[CrossRef][Medline]
Natividad Ruiz
Department of Molecular Biology
Princeton University
Princeton, New Jersey 08544
Phone: (609) 258-9518
Fax: (609) 258-2957
E-mail: nruiz{at}princeton.edu


Antimicrobial Agents and Chemotherapy, August 2009, p. 3604-3605, Vol. 53, No. 8
0066-4804/09/$08.00+0     doi:10.1128/AAC.00578-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Fay, A., Dworkin, J. (2009). Bacillus subtilis Homologs of MviN (MurJ), the Putative Escherichia coli Lipid II Flippase, Are Not Essential for Growth. J. Bacteriol. 191: 6020-6028 [Abstract] [Full Text]  

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ruiz, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruiz, N.